{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:29:24Z","timestamp":1790882964021,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1635,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.rmed.2008.10.024","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T04:52:44Z","timestamp":1231476764000},"page":"342-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma"],"prefix":"10.1016","volume":"103","author":[{"given":"Susan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Balachandra","family":"Dass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore F.","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Knorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2008.10.024_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1368-5031.2004.00182.x","article-title":"Managing asthma in the real world","volume":"58","author":"Gillissen","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.rmed.2008.10.024_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1398-9995.2004.00526.x","article-title":"Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report","volume":"59","author":"Masoli","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2008.10.024_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pharmthera.2005.08.001","article-title":"Novel signal transduction modulators for the treatment of airway diseases","volume":"109","author":"Barnes","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.rmed.2008.10.024_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"Chung","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.rmed.2008.10.024_bib5","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2174\/092986706778773040","article-title":"Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD","volume":"13","author":"Huang","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.rmed.2008.10.024_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1517\/13543784.16.1.109","article-title":"Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast","volume":"16","author":"Kroegel","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.rmed.2008.10.024_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1081-1206(10)61065-4","article-title":"Efficacy and safety of roflumilast in the treatment of asthma","volume":"96","author":"Bateman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmed.2008.10.024_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1398-9995.2005.00931.x","article-title":"Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma","volume":"61","author":"Bousquet","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2008.10.024_bib9","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.bcp.2007.03.010","article-title":"L-454,560, a potent and selective PDE4 inhibitor with in vivo efficacy in animal models of asthma and cognition","volume":"73","author":"Huang","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.rmed.2008.10.024_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1183\/09031936.97.10030646","article-title":"Measurement characteristics of two asthma symptom diary scales for use in clinical trials","volume":"10","author":"Santanello","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2008.10.024_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2008.10.024_bib12","series-title":"Diagnosis and management of asthma","author":"National Asthma Education and Prevention Program (NAEPP) Expert Panel Report 3","year":"2007"},{"key":"10.1016\/j.rmed.2008.10.024_bib13","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1046\/j.1365-2222.1999.00667.x","article-title":"Serum eosinophilic cationic protein and blood eosinophil counts for the prediction of the presence of airways inflammation in children with wheezing","volume":"29","author":"Shields","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmed.2008.10.024_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/ai.1994.v94.a55250","article-title":"Pulmonary function, activated T cells, peripheral blood eosinophilia, and serum activity for eosinophil survival in vitro: a longitudinal study in bronchial asthma","volume":"94","author":"Virchow","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2008.10.024_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa050580","article-title":"Evidence of a role of tumor necrosis factor alpha in refractory asthma","volume":"354","author":"Berry","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2008.10.024_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1465-9921-7-125","article-title":"Role of TNFalpha\u00a0in pulmonary pathophysiology","volume":"7","author":"Mukhopadhyay","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.rmed.2008.10.024_bib17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2222.2007.02695.x","article-title":"Lower airways inflammation in allergic rhinitics: a comparison with asthmatics and normal controls","volume":"37","author":"Brown","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmed.2008.10.024_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1358\/dnp.2006.19.4.985935","article-title":"Are there any realistic chances to develop new drugs for asthma?","volume":"19","author":"Amon","year":"2006","journal-title":"Drug News Perspect"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611108003806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611108003806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:51:05Z","timestamp":1760611865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611108003806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0954611108003806"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2008.10.024","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2008.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}